|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Erlotinib in previously treated non-small-cell lung cancer 显示文摘 | Shepherd FA Rodrigues Pereira J Ciuleanu T | 2005 | N Engl J Med2005，353，2： | 1 |
| 2 | Optimizing treat-ment for patients with metastatic renal cell carcinoma in the Centraland Eastern European region 显示文摘 | Vrdoljak E Ciuleanu T Kharkevich G | 2012 | Expert Opin Pharmacother2012，13，2： | 1 |
| 3 | Erlotinib in previ- ously treated non- small -cell lung cancer显示文摘 | Shepherd FA Rodrigues PJ Ciuleanu T | 2005 | N Engl J Med2005，353，2： | 1 |
| 4 | Erlotinib as mainte- nance treatment in advanced non-small-cell lung cancer: a multi- centre, randomised, placebo-controlled phase 3 study 显示文摘 | Cappuzzo F Ciuleanu T Stelmakh L | 2010 | Lancet oncol2010，11，6： | 1 |
| 5 | Erlotinib in previously treated non-small-cell lung cancer显示文摘 | Shepherd FA Rodrigues pereira J Ciuleanu T | 2005 | N Engl J Med2005，353，2： | 1 |
| 6 | Erlotinib in previously treated non-small-cell lung cancer 显示文摘 | Shepherd F A Rodfigues Pereira J Ciuleanu T | 2005 | N EngL J Med2005，353，2： | 1 |
| 7 | Erlotinib in previ-ously treated non-small cell lung cancer 显示文摘 | Shepherd FA Rodrigues J Ciuleanu T | 2005 | N Engl J Med2005，353，5： | 1 |
| 8 | Erlotinib in previously treated non-small cell lung cancer显示文摘 | Shepherd FA Rodrigues Pereira J Ciuleanu T | 2005 | N Engl J Med2005，353，： | 1 |
| 9 | Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer:a randomised,double-blind,phase 3 study显示文摘 | Ciuleanu T Brodowicz T Zielinski C | | 0，，： | 1 |
| 10 | Erlotinib in previ- ously treated non-small-cell lung cancer显示文摘 | Shepherd FA Rodrigues Pereira J Ciuleanu T | 2005 | N Engl J Med2005，353，： | 1 |
| 11 | Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study显示文摘 | Ciuleanu T Brodowicz T Zielinski C | 2009 | Lancet2009，374，： | 1 |
| 12 | Erlotinib as main- tenance treatment in advanced non-small-cell lung cancer: amulticentre, randomized, placebo- controlled phase 3 study 显示文摘 | Cappuzzo F Ciuleanu T Stelmakh L | 2010 | Lanct Oncol2010，11，6： | 1 |
| 13 | Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer:a randomised, double-blind, phase 3 study 显示文摘 | Ciuleanu T | 2009 | Lancet2009，374，9699： | 1 |
| 14 | Erlotinib in previously treated non-small-cell lung cancer显示文摘 | Shepherd FA Rodrigues PJ Ciuleanu T | | 0，，02： | 1 |
| 15 | Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non small-cell lung cancer:A randomised, double-blind, phase 3 study显示文摘 | Ciuleanu T Brodowicz T Zielinski C | 2009 | Lancet2009，374，9： | 1 |
| 16 | Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer:a randomized,double-blind,phase 3 study显示文摘 | Ciuleanu T Brodowicz T Zielinski C | 2009 | Lancet2009，374，9699： | 1 |
| 17 | Erlotinib in previonsly treated non-small-cell lung cancer显示文摘 | Shepherd FA Pereira JR Ciuleanu T | 2005 | N Engl J Med2005，353，2： | 1 |
| 18 | Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer:a randomised,double-blind,phase 3 study显示文摘 | Ciuleanu T Brodowicz T Zielinski C | | 0，，9699： | 1 |
| 19 | Erlotinib as maintenance treatment in advanced non-small-cell lung cancer:a multicentre,randomised,placebo-controlled phase 3 study显示文摘 | Cappuzzo F Ciuleanu T Stelmakh L | | 0，，06： | 1 |
| 20 | A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumb in the first-line treatment of advanced non-squamous non-samll cell lung cance显示文摘 | Ciuleanu T Tsai M Tsao J | 2013 | Lung Cancer2013，82，8： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员